Valens Semiconductor Exceeds Q1 Expectations, Reaffirms FY2026 Revenue Guidance Amid Measured Recovery
Valens Semiconductor reported Q1 2026 revenue of $16.9M and gross margin of 62.2% above guidance, with a better-than-expected adjusted EBITDA loss, while reiterating full-year revenue guidance of $75M-$77M, signaling confidence in a stronger second half driven by CIB growth and product cycle execution.
Valens Semiconductor Ltd. (NYSE:VLN) reported first-quarter 2026 financial results that modestly exceeded expectations, with management reaffirming its full-year revenue guidance despite a sequentially slower quarter. The company posted revenue of $16.9 million, compared with $19.4 million in the fourth quarter of 2025 and $16.8 million in the year-ago period. GAAP gross margin reached 62.2%, above the company's guidance range of 57.0%–59.0%. Adjusted EBITDA loss came in at $(5.5) million, better than the guided range of $(7.9) million to $(7.5) million. The results were highlighted in an update from Stonegate Capital Partners, which covers the company.
While revenue stepped down sequentially following a stronger fourth quarter, the results were ahead of expectations and management reiterated its fiscal year 2026 revenue guidance of $75.0 million to $77.0 million. The company views 2026 as a year of measured recovery and product-cycle execution, with near-term growth expected to build through the year. Key drivers include a return to sequential growth in the Commercial, Industrial, and Broadcast (CIB) segment, steady automotive performance, and continued development of the A-PHY ecosystem. Management noted that broader supply-chain conditions remain an area to monitor but stated that it does not see risk to meeting its full-year targets.
The second half of 2026 is expected to be meaningfully stronger, driven by CIB sequential growth, momentum in the ProAV market, and design wins and design-ins converting into customer launches in the third and fourth quarters. Automotive revenue grew to $5.9 million in the first quarter, while the VA7000 product line is gaining traction in industrial machine vision and medical endoscopy, expanding the addressable opportunity beyond core A-PHY automotive applications. However, revenue contribution from these adjacent markets likely remains several quarters out.
Stonegate Capital Partners, a capital markets advisory firm providing investor relations and equity research services, updated its coverage on Valens Semiconductor. The firm noted that execution remains ahead of plan despite a slower first-half setup. The full announcement, including downloadable images and bios, is available here. Stonegate Capital Markets, a member of FINRA, provides investment banking services for public and private companies.